1. Home
  2. ROMA vs IMUX Comparison

ROMA vs IMUX Comparison

Compare ROMA & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROMA
  • IMUX
  • Stock Information
  • Founded
  • ROMA 2018
  • IMUX 2016
  • Country
  • ROMA Hong Kong
  • IMUX United States
  • Employees
  • ROMA N/A
  • IMUX N/A
  • Industry
  • ROMA Savings Institutions
  • IMUX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROMA Finance
  • IMUX Health Care
  • Exchange
  • ROMA Nasdaq
  • IMUX Nasdaq
  • Market Cap
  • ROMA 58.1M
  • IMUX 67.8M
  • IPO Year
  • ROMA 2024
  • IMUX N/A
  • Fundamental
  • Price
  • ROMA $3.92
  • IMUX $0.95
  • Analyst Decision
  • ROMA
  • IMUX Strong Buy
  • Analyst Count
  • ROMA 0
  • IMUX 5
  • Target Price
  • ROMA N/A
  • IMUX $7.50
  • AVG Volume (30 Days)
  • ROMA 252.8K
  • IMUX 1.1M
  • Earning Date
  • ROMA 08-05-2025
  • IMUX 08-11-2025
  • Dividend Yield
  • ROMA N/A
  • IMUX N/A
  • EPS Growth
  • ROMA N/A
  • IMUX N/A
  • EPS
  • ROMA N/A
  • IMUX N/A
  • Revenue
  • ROMA $1,029,120.00
  • IMUX N/A
  • Revenue This Year
  • ROMA N/A
  • IMUX N/A
  • Revenue Next Year
  • ROMA N/A
  • IMUX N/A
  • P/E Ratio
  • ROMA N/A
  • IMUX N/A
  • Revenue Growth
  • ROMA N/A
  • IMUX N/A
  • 52 Week Low
  • ROMA $0.46
  • IMUX $0.56
  • 52 Week High
  • ROMA $4.66
  • IMUX $2.11
  • Technical
  • Relative Strength Index (RSI)
  • ROMA 60.19
  • IMUX 54.43
  • Support Level
  • ROMA $3.82
  • IMUX $0.94
  • Resistance Level
  • ROMA $4.66
  • IMUX $1.18
  • Average True Range (ATR)
  • ROMA 0.32
  • IMUX 0.08
  • MACD
  • ROMA 0.02
  • IMUX 0.00
  • Stochastic Oscillator
  • ROMA 48.58
  • IMUX 38.16

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Share on Social Networks: